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A 54-year-old woman presented to the emergency room with 3months of slurred speech,
language problems, and right hemiparesis. Initial impression based on history, exam, and
imaging was brain abscess vs. primary or metastatic neoplasm. Brain biopsy of the lesion
and pathologic specimens were obtained. Below is a description of her presentation,
hospital course, imaging, and pathology, as well as a short discussion of the ﬁnal diagnosis.
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A 54-year-old right handed woman presented to the emergency
department with complaints of slurred speech and right foot
heaviness. She ﬁrst noticed the symptoms 3weeks earlier, and asso-
ciated it with fatigue. However, the symptoms progressed, and she
eventually also noticed difﬁculty thinking of the “right words to
say.” She stated that she sometimes forgot words, as if she had
trouble “getting them out.” By the time of presentation her right
foot was very “heavy”; if she did not lift her leg high enough she
would stumble. She had no headaches, nausea, vomiting, fevers,
night sweats, visual, or sensory complaints.
She had a past medical history of depression, but no hyper-
tension, hyperlipidemia, or diabetes. She was married, and had
smoked 1/2 packs of cigarettes per day for the past 5 years. She
drank a glass of wine per day and did not use any illicit substances.
In the 3-years she had been out of the country two times – to
Guatemala and Belize. Her family history was remarkable for a
mother with an atrial myxoma, father with renal cell cancer and
spinal malignancies, and a brother with a spindle cell tumor of the
left arm. There was no family history of cardiovascular disease.
Review of systems was unremarkable.
Bloodpressure andother vital signswere normal.General phys-
ical examination was unremarkable. Neurologic examination was
remarkable for slurred impaired ﬂuency and repetition, with pre-
served comprehension, reading, and writing. She had a right lower
facial droop, right pronator drift, andmild right hemiparesis.Mus-
cle stretch reﬂexes were brisk and symmetric. Plantar responses
were ﬂexor. She had decreased dexterity on the right and an
unsteady gait, with slight circumduction of her right leg.
Laboratory testing showed normal blood indices (normalwhite
blood cell differential), and a normal metabolic proﬁle. Chest
radiographwas unremarkable. Cranial computerized tomography
(CT) showed a low density mass with peripheral high attenuation
rimwithin the left frontal lobe with adjacent vasogenic edema and
trace midline shift (Figure 1).
Magnetic resonance imaging (MRI) of her brain showed a
3.1-cm× 2.3-cm× 1.9-cm rim-enhancing left posterior frontal
intra-axial mass that mildly restricted diffusion in the periphery
and did not have a hemorrhagic component (Figure 2). Differen-
tial diagnosis of the lesion based on history, exam, and imaging
included subacute/chronic infectious, neoplastic (primary brain
vs. metastatic), and demyelinating processes. Empiric antibiotics
and dexamethasone were started for initial concern of abscess and
mild mass effect. Stereotactic brain biopsy of the lesion in the left
frontal lobe was obtained.
FIGURE 1 | Non-contrast cranial CT upon presentation.
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FIGURE 2 | Coronal post-gadoliniumT1-weighted MRI shows a mass in
the subcortical left frontoparietal region abutting into the left lateral
ventricle with associated peripheral ring-like enhancement.
FIGURE 3 | H and E staining shows brain parenchyma with focal
lymphocytic infiltrates, numerous macrophages and reactive gliosis
(A) and perivascular lymphocytic infiltrates (B,C).
FIGURE 4 | H and E staining remarkable for astrocytes with
fragmented nuclear inclusions (Creutzfeldt-Peters cells) and numerous
lipid-laden macrophages.
PATHOLOGY
DISCUSSION
Histology sections revealed brain parenchyma with evidence of
demyelination, perivascular lymphocytic inﬁltrates,macrophages,
reactive gliosis, and relative preservation of axons; consistent with
a demyelinating process. There were no cells to suggest neoplastic
atypia. Gram,Grocott methenamine silver (GMS),AFB, and SV40
stains were negative for microorganisms. A diagnosis of tumefac-
tive multiple sclerosis (MS) wasmade based on her clinical history
and imaging with the pathologic diagnosis (Figures 3–6).
Tumefactive MS is a rare variant of MS characterized by the
presence of large demyelinating plaques (>2 cm) on MRI (Pit-
tock et al., 2005). Other atypical imaging features include mass
effect, edema, and/or post-gadolinium enhancement (Lucchinetti
et al., 2008). Potential gadolinium-enhancing patterns of tumefac-
tive MS include ring (closed-ring most common), heterogeneous
(punctuate and nodular), patchy and diffuse, cotton-ball, and
homogeneous (Lucchinetti et al., 2008). Patients may present with
a variety of clinical manifestations depending on the size and loca-
tion of the lesion.Acute aphasiamay be a commonpresentation, as
in our patient, and is not necessarily indicative of a poor prognosis
(Lacour et al., 2004).
FIGURE 5 | Glial fibrillary acidic protein staining shows relative a
reactive gliosis pattern.
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FIGURE 6 | Luxol fast blue [control (A), patient (B)] shows relative destruction and loss of myelin with neurofilament staining (C) showing relative
axonal preservation.
FIGURE 7 | Comparison of brain MRI at presentation (May 30, 2010) and follow-up (December 1, 2010) showing a discrete contiguous lesion just
posterior to the previous one.
Radiologically, the lesions may mimic neoplasms, and are typi-
cally supratentorial (Hu and Lucchinetti, 2009). Pathology reveals
hypercellular conﬂuent demyelinating lesions with inﬂammatory
inﬁltrates, dominated by myelin-laden macrophages. There is
relative axonal preservation. Creutzfeldt-Peters cells (Figure 4),
astrocytes with fragmented nuclear inclusions, are present and
may be confused with mitotic cells seen in glioblastoma (Hu
and Lucchinetti, 2009). Most patients with initial presentation
of tumefactive MS go on to develop a relapsing-remitting type
MS. There are, however, rare reports of relapsing-remitting MS
of the tumefactive type (Selkirk and Shi, 2005). Tumefactive
lesions can also be associated with spontaneous intracranial
hemorrhage. Magnetic resonance spectroscopy (mRS) gener-
ally shows decreased N -acetylaspartate (NAA)/creatinine (Cr)
ratio, an increased choline (Cho)/Cr ratio, and presence of
glutamate/glutamine or lactate peaks. These ﬁndings, however,
are observed in various disease conditions (including neopla-
sia) and thus are not helpful in differentiating large tume-
factive lesions from neoplasms (Kiriyama et al., 2010). More-
over, the imaging characteristics on mRS are not seen in all
tumefactive demyelinating lesions, and thus biopsy is some-
times essential to diagnose patients presenting with tumefactive
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demyelination and no history of demyelinating disease (Kiriyama
et al., 2010).
Acute exacerbations of tumefactive MS are treated with high-
dose intravenous steroids and plasma exchange (Nilsson et al.,
2009). In cases of malignant cerebral edema, hemicraniectomy
has been recommended and can be a life-saving measure (Gorm-
ley and Zajicek, 2006; Nilsson et al., 2009). Immunomodulating
agents may be necessary with a relapsing-remitting course or with
progressive tumefactive demyelination despite above measures.
In addition to traditional medications used to treat relapsing-
remitting MS, case studies have shown favorable outcomes using
Rituximab (Leussink et al., 2008), Mitoxantrone (Jeffery et al.,
2004), Alemtuzumab (Gormley and Zajicek, 2006), and stem cell
transplantation (Kimiskidis et al., 2007) in treating tumefactive
demyelinating lesions.
Our patient was started on methylprednisolone with
marked improvement of her weakness and language difﬁculty.
Post-operative course was complicated by lower extremity deep
vein thrombosis (DVT) and pulmonary embolism treated with
warfarin for 6months. After treatment with steroids and anticoag-
ulation a lumbar puncture was done, andwas unremarkable [cere-
brospinal ﬂuid oligoclonal bands negative (Hu and Lucchinetti,
2009), IgG index normal (0.62)].
Several months later she complained of increased fatigue, right
arm and thigh swelling, and worsening dexterity of her right
hand. Repeat imaging was remarkable for a discrete, contiguous
enhancing hyperintense lesion just posterior to the previous one
(Figure 7).
She was readmitted for plasmapheresis and discharged on oral
prednisone and Rituximab for relapsing-remitting tumefactive
MS. On recent follow-up, approximately 1 year after initial presen-
tation, she was noted to have a residual mild motor aphasia and
spastic right hemiparesis. She has had no further clinical relapses
to date.
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